Audax Group Announces Acquisition of Chesapeake IRB
Thu, 01 Jan 1970 00:00:00 GMT
BOSTON--(BUSINESS WIRE)--Audax Group announced it has completed the recapitalization of Chesapeake Research Review, Inc., d/b/a Chesapeake IRB (“Chesapeake”). Headquartered in Columbia, Maryland, Chesapeake is a leading provider of independent institutional review board (“IRB”) services to major pharmaceutical, biotech and medical device companies, universities, academic medical centers, and hospital systems. Chesapeake performs independent reviews of proposed research projects and principal inv
read more
Novo A/S acquires Xellia Pharmaceuticals for US$ 700 million
Thu, 01 Jan 1970 00:00:00 GMT
OSLO & COPENHAGEN--(BUSINESS WIRE)--Novo A/S, a holding company of the Novo Group has acquired anti-infective developers and manufacturers Xellia Pharmaceuticals for US$ 700 million
read more
AmerisourceBergen Corporation Completes $308 Million Divestiture of
Mon, 13 May 2013 00:00:00 GMT
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!AmerisourceBergen Completes Divestiture of AndersonBreconSEATTLE and PHILADELPHIA, May 13, 2013 /PRNewswire/ -- Frazier...
read more
Quintiles prices IPO at $40 per share
Thu, 09 May 2013 11:40:00 GMT
Quintiles has announced the pricing of its initial public offering of 23,684,210 shares of its common stock at a price to the public of $40.00 per share. The shares of Quintiles common stock are expected to begin trading on the New York Stock Exchange under the single-letter symbol "Q” on May 9, 2013.
read more
Octopus Leads TrialReach Funding
Wed, 08 May 2013 09:04:57 GMT
Octopus has led a 2 million pound ($3.1 million) investment round into TrialReach, an online platform that is transforming clinical trials by connecting patients with healthcare companies and research organisations to make new treatments available more quickly and efficiently. Octopus is investing alongside existing investors Amadeus Capital Partners, which first invested in TrialReach in 2011.The post Octopus Leads TrialReach Funding appeared first on peHUB.
read more
TFS International acquires Beardsworth Consulting Group
Mon, 06 May 2013 11:37:00 GMT
In a move to expand its oncology and vaccine research services, TFS International, a full service CRO, has completed the acquisition of Beardsworth Consulting Group (BCG), a New Jersey-based oncology and vaccine specialist CRO.
read more
Frazier Healthcare Acquires AndersonBrecon from AmerisourceBergen
Tue, 02 Apr 2013 12:30:00 GMT
PHILADELPHIA, April 2, 2013 /PRNewswire/ -- Frazier Healthcare is pleased to announce that it has signed a definitive agreement to acquire AndersonBrecon, the contract pharmaceutical packaging business and wholly owned subsidiary of AmerisourceBergen Corporation (NYSE: ABC). ...
read more
LabCorp, BMS Deal Could Spell Trouble for Icon, Analyst Says
Tue, 02 Apr 2013 21:59:14 GMT
B-MS' (Bristol-Myers Squibb's) selection of LabCorp as its preferred provider for central lab services could be bad news for rival Icon according to industry observers.
read more
The PRACS Institute Has Shut Down According to Media Reports
Thu, 21 Mar 2013 11:58:07 GMT
The PRACS Institute – the firm that emerged from the ashes of Cetero Research
– has shut down operations at all locations according to local media reports.
read more
Grifols Buys 60 Pct of Progenika, Net Profit of $334 Million
Fri, 08 Mar 2013 00:00:00 GMT
Barcelona (ACN).- Grfols has bought 60% of the Basque biotechnology company Progenika Biopharmas capital, an investment of 37 million. The Catalan company is the worlds third leader in blood derivatives pharmaceutical products. The pharmaceutical company, which is based in Greater Barcelona, posted a net profit of 256.7 million for 2012, which quadruples the previous years results. In 2012, Gr...
read more
Shane C. Senior, CFA
